APA (7th ed.) Citation

A, P., S, R., F, P., SE, B., M, B., L, D. C., . . . S, G. (2023). BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Cancer research, 83(10), 1699. https://doi.org/10.1158/0008-5472.CAN-22-2620

Chicago Style (17th ed.) Citation

A, Petrelli, et al. "BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors." Cancer Research 83, no. 10 (2023): 1699. https://doi.org/10.1158/0008-5472.CAN-22-2620.

MLA (9th ed.) Citation

A, Petrelli, et al. "BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors." Cancer Research, vol. 83, no. 10, 2023, p. 1699, https://doi.org/10.1158/0008-5472.CAN-22-2620.